Tech Company Financing Transactions
Actuate Therapeutics Funding Round
On 5/20/2019, Actuate Therapeutics announced $21.7 million in Series B funding from Kairos Ventures, Bios Partners and DEFTA Partners.
Transaction Overview
Company Name
Announced On
5/20/2019
Transaction Type
Venture Equity
Amount
$21,700,000
Round
Series B
Investors
Proceeds Purpose
Actuate will use the proceeds of the financing to expand the company's ongoing Phase 1 / 2 clinical trial and fund development programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1751 River Run 400
Fort Worth, TX 76107
USA
Fort Worth, TX 76107
USA
Phone
Website
Email Address
Overview
Actuate is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutic agents for patients with cancer or inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Schmitt
Chief Medical Officer
Francis Giles
Co-Founder
Andrew Maza
Browse more venture capital transactions:
Prev: 5/20/2019: Retail Zipline venture capital transaction
Next: 5/20/2019: Deliveroo venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs